New drug cuts severe COPD flare-ups by 30%, study shows

An experimental drug is offering new hope for the millions of Americans living with COPD. In late-stage clinical trials, an antibody treatment called Tozorakimab reduced scary, damaging lung flare-ups by up to 30%. Dr. Stephen Miranda from Mount Sinai broke down what this breakthrough means for lung health, plus how a little "laughter therapy" might also help patients breathe easier.